APP and Alzheimer disease: The HFD mice had higher protein levels of APP, Tau, p-Tau, and Aβ oligomers in the cerebral cortex, while TBG096 treatment significantly reduced the expression of these proteins in the brains of AD mice (Figure 5L,M and Figure S7E,F), respectively.